Professor of Medicine, University Fla College of Medicine
Cardiology
Dr. Carl J. Pepine, MD
|
|
Give Review
Carl Pepine practices Cardiology. He went to medical school at Rutgers New Jersey Medical School. Rutgers New Jersey Medical School has a rank of 76 in research and a 0 in primary care He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Women's Health", "Men's Health", "Top Doctors: Florida", "Elected Member" and "Whos Who in Medicine and Healthcare". Dr. Carl J. Pepine has written publications. He has 98 publications published with PubMed. The lastest paper is: 'Genetic Loci Associated With Nonobstructive Coronary Artery Disease in Caucasian Women.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Genetic Loci Associated With Nonobstructive Coronary Artery Disease in Caucasian Women.
- Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-Myocardial ischemia.
- Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.
- Cardiac Magnetic Resonance Myocardial Perfusion Reserve Index Is Reduced in Women With Coronary Microvascular Dysfunction: A National Heart, Lung, and Blood Institute-...
- Mild renal dysfunction and long-term adverse outcomes in women with chest pain: Results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia S...
- Bone Marrow Characteristics Associated with Changes in Infarct Size after STEMI: A Biorepository Evaluation from the CCTRN TIME Trial.
- Microvascular Coronary dysfunction and ischemic heart disease: Where are we in 2014?
- Efficacy and Safety of Angiotensin Receptor Blockers in Older Patients: A Meta-Analysis of Randomized Trials.
- Assessing cardiovascular risk in women: Looking beyond traditional risk factors.
- Impact of Aspirin According to Type of Stable Coronary Artery Disease: Insights from a Large International Cohort.
- Usefulness of Beta Blockade in Contemporary Management of Patients With Stable Coronary Heart Disease.
- Reply to 'Resistant Hypertension revisited: definition and true prevalence'.
- Aldosterone inhibition and Coronary endothelial function in women without obstructive Coronary artery disease: An ancillary study of the National Heart, Lung, and Bloo...
- Some thoughts on the continuing dilemma of Angina pectoris.
- Bone marrow mononuclear cell therapy for Acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
- A microvascular-Myocardial diastolic dysfunctional state and risk for mental stress ischemia: a revised concept of ischemia during daily life.
- The Prevalence of Microvascular Dysfunction, Its Role Among Men, and Links with Adverse Outcomes: Non-Invasive Imaging Reveals the Tip of the Iceberg.
- Comparison of low and high dose intraCoronary adenosine and acetylcholine in women undergoing Coronary reactivity testing: Results from the NHLBI-sponsored Women's Isc...
- Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
- Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.
- Implementation of Cardovascular Cell Therapy Network trials: challenges, innovation and lessons learned from experience in the CCTRN.
- One-Year Follow-up of IntraCoronary Stem Cell Delivery on Left Ventricular Function Following ST-Elevation Myocardial Infarction.
- Predictors and outcomes of resistant hypertension among patients with Coronary artery disease and hypertension.
- The Editor's Roundtable: The 10Q Report - Advancing women's Heart health through improved research, diagnosis, and treatment.
- Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.
- Antagonist molecules in the treatment of Angina.
- The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
- A critical analysis of clinical outcomes reported in stem cell trials for Acute myocardial infarction: some thoughts for design of future trials.
- Cardiovascular care for women: the 10-Q Report and beyond.
- Diminazene Aceturate Enhances Angiotensin-Converting Enzyme 2 Activity and Attenuates Ischemia-Induced Cardiac Pathophysiology.
- Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive Coronary artery disease: Findings from the National Heart, Lung, and Blo...
- Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.
- Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents.
- Coronary Angiography: Is it Time to Reassess?
- Increased wave reflection and ejection duration in women with chest pain and nonobstructive Coronary artery disease: ancillary study from the Women's Ischemia Syndrome...
- Phase II Clinical Research Design in Cardiology: Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Ne...
- Effects of pharmacologic therapy on health-related quality of life in elderly patients with Atrial fibrillation: a systematic review of randomized and nonrandomized tr...
- Calcium antagonists in the treatment of Coronary artery disease.
- Loci influencing blood pressure identified using a cardiovascular gene-centric array.
- Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
- Genetic Variation in PEAR1 is Associated with Platelet Aggregation and Cardiovascular Outcomes.
- Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse Hypertensive case control cohort.
- Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in Hypertensive patients treated with thiazide diuretics.
- A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after Myocardial infarction.
- G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in Hypertension.
- Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
- Treatment of Hypertension: Lower Is Better, or Is It?
- Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
- Relationships Between Cardiovascular Disease Risk Factors and Depressive Symptoms as Predictors of Cardiovascular Disease Events.
- In women with symptoms of cardiac ischemia, nonobstructive Coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated wit...
- Syndrome x and microvascular Coronary dysfunction.
- What causes myocardial infarction in women without obstructive Coronary artery disease?
- Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women's Ischemia Syndrome Evaluation (WISE) Ancillary Study.
- Response to letter regarding article "chromosome 9p21 haplotypes and prognosis in white and black patients with Coronary artery disease".
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensu...
- Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antiHypertensive therapy: results from the INVEST-GENES study.
- Harmful Effects of Nonsteroidal Anti-inflammatory Drugs among Patients with Hypertension and Coronary Artery Disease.
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consens...
- Chromosome 9p21 haplotypes and prognosis in white and black patients with Coronary artery disease.
- Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
- Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antiHypertensive-treated patients.
- An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive Coronary artery disease: a substudy from the National Heart, Lung a...
- A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with Acute coronary syndromes undergoing percutaneous coronary intervention.
- Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational V...
- Endothelium as a predictor of adverse outcomes.
- DHEA-S levels and cardiovascular Disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (...
- Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive Coronary disease: results from the NHLBI-spon...
- Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
- Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).
- Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.
- Blood pressure and outcomes in very old hypertensive Coronary artery disease patients: an INVEST substudy.
- Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and Coronary artery disease.
- Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in review.
- Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
- Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Insti...
- A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive Coronary artery disease: results from the ...
- Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national Heart, lung, and blood insti...
- Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
- Aromatase gene polymorphisms are associated with survival among patients with cardiovascular Disease in a sex-specific manner.
- Outcomes Among hypertensive patients with concomitant peripheral and Coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.
- Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
- CACNA1C gene polymorphisms, cardiovascular Disease outcomes, and treatment response.
- Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in Hypertension.
- Adverse cardiovascular outcomes in women with nonobstructive Coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Wom...
- Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-spons...
- The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and Hypertension: a moderated panel discussion.
- The impact of nitric oxide in cardiovascular medicine: untapped potential utility.
- Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controll...
- Characteristics and outcomes of revascularized patients with Hypertension: an international verapamil SR-trandolapril substudy.
- Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.
- Insulin as a cardiovascular therapeutic: improving glycemic control in patients with Coronary artery disease.
- Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
- Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in Hypertension.
- beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in Hypertension.
- Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE).
- Provoked coronary spasm and Acute coronary syndromes.
- Postmarket evaluation of breakthrough technologies.
Schools
University of Medicine And Dentistry of New Jersey Newark
Allegheny Gen Hospital
Naval Reg Med Center
Thos Jefferson University Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardioversion, Elective
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Women's Health
- Men's Health
- Top Doctors: Florida
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Thomas Jefferson University -
Allegheny General Hospital - Western Pennsylvania Hospital -
Rutgers New Jersey Medical School
Hospital
-
UF Health Shands Hospital
Drug Facts
| NPI NUMBER | 1033124789 | |
| NPPES Provider LastName | PEPINE | |
| NPPES Provider FirstName | CARL | |
| NPPES Provider ZIPCode | 326100371 | |
| NPPES Provider State | FL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1098.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033124789 |
| Last Name Of The Provider | PEPINE |
| First Name Of The Provider | CARL |
| View All |
Similar Doctors
|
|
Dr. Julio E. Schwarz, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel Van Roy, MD |
|
Dr. Matheen A. Khuddus, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven F. Roark, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael C. Dillon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James J. O'Meara III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moise W. Anglade, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher P. Caputo, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Burkart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marian C. Limacher, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jay C. Koons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary R. Cooper, MD |
|
|
Dr. Ryan J. Chauffe, DO |
|
|
Dr. Carsten M. Schmalfuss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph C. Hymas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajay J. Mehta, MD |